Just been looking at there tier 1 and 2 product candidates inpressive,all these products are well advanced also these products incoporate other companies (Anglioblast,Osiris and Jcr) previous research.Osiris spent millions on getting its product through trials which were not that successfull obviously Mesoblast has researched these previous trials and corrected the issues that caused the trials to show little or no efficacy and continued on with the trials.In regards to the market correction it is just short term and a major over reaction, nothing has really changed.More positive announcements will be issued after Dec 7.I say hang in there.
Maxim, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |